4/24
04:14 pm
me
23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]
Low
Report
23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]
4/24
04:05 pm
me
23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Low
Report
23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
4/18
08:00 am
me
23andMe announces CEO’s intention to pursue a potential take-private
High
Report
23andMe announces CEO’s intention to pursue a potential take-private
4/17
01:19 pm
me
Can 23andMe Holding (NASDAQ:ME) Afford To Invest In Growth? [Yahoo! Finance]
Low
Report
Can 23andMe Holding (NASDAQ:ME) Afford To Invest In Growth? [Yahoo! Finance]
4/16
10:55 am
me
23andMe Holding Co. (NASDAQ: ME) had its price target lowered by analysts at Citigroup Inc. from $0.85 to $0.47. They now have a "neutral" rating on the stock.
Low
Report
23andMe Holding Co. (NASDAQ: ME) had its price target lowered by analysts at Citigroup Inc. from $0.85 to $0.47. They now have a "neutral" rating on the stock.
4/5
04:17 pm
me
23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024 [Yahoo! Finance]
Low
Report
23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024 [Yahoo! Finance]
4/5
04:05 pm
me
23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024
Low
Report
23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024
3/20
07:45 am
me
23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6 [Yahoo! Finance]
Low
Report
23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6 [Yahoo! Finance]
3/20
07:30 am
me
23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
Medium
Report
23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
3/19
08:13 am
me
23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago [Yahoo! Finance]
Low
Report
23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago [Yahoo! Finance]
3/19
08:00 am
me
23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago
Low
Report
23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago
3/6
07:38 am
me
23andMe Launches New Genetic Reports on Common Forms of Cancer [Yahoo! Finance]
Low
Report
23andMe Launches New Genetic Reports on Common Forms of Cancer [Yahoo! Finance]
3/6
07:30 am
me
23andMe Launches New Genetic Reports on Common Forms of Cancer
Low
Report
23andMe Launches New Genetic Reports on Common Forms of Cancer
3/5
04:43 pm
me
23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024 [Yahoo! Finance]
Medium
Report
23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024 [Yahoo! Finance]
3/5
04:30 pm
me
23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024
Low
Report
23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024
2/27
12:15 pm
me
Levi & Korsinsky Reminds 23andMe Consumers of an Investigation into Recent Data Breach
Low
Report
Levi & Korsinsky Reminds 23andMe Consumers of an Investigation into Recent Data Breach
2/26
12:15 pm
me
23andMe Holding Co (NASDAQ:ME) Jewish and Chinese Users
Medium
Report
23andMe Holding Co (NASDAQ:ME) Jewish and Chinese Users
2/22
12:10 pm
me
23andMe Holding Co (NASDAQ: ME) Jewish and Chinese Users
Low
Report
23andMe Holding Co (NASDAQ: ME) Jewish and Chinese Users
2/21
12:15 pm
me
23andMe Data Breach - Hackers Targeted Jewish and Chinese Users Data
Low
Report
23andMe Data Breach - Hackers Targeted Jewish and Chinese Users Data
2/20
12:15 pm
me
23andMe Holding Co (NASDAQ:ME) Jewish and Chinese Users
Low
Report
23andMe Holding Co (NASDAQ:ME) Jewish and Chinese Users
2/16
12:15 pm
me
Levi & Korsinsky Reminds 23andMe Consumers of an Investigation into Recent Data Breach
Low
Report
Levi & Korsinsky Reminds 23andMe Consumers of an Investigation into Recent Data Breach
2/15
12:15 pm
me
Levi & Korsinsky Reminds 23andMe Consumers of an Investigation into Recent Data Breach
Low
Report
Levi & Korsinsky Reminds 23andMe Consumers of an Investigation into Recent Data Breach
2/14
12:15 pm
me
Levi & Korsinsky Reminds 23andMe Consumers of an Investigation into Recent Data Breach
Low
Report
Levi & Korsinsky Reminds 23andMe Consumers of an Investigation into Recent Data Breach
2/13
12:15 pm
me
23andMe Holding Co (NASDAQ: ME) Jewish and Chinese Users
Low
Report
23andMe Holding Co (NASDAQ: ME) Jewish and Chinese Users
2/12
12:10 pm
me
Levi & Korsinsky Reminds 23andMe Consumers of an Investigation into Recent Data Breach
Medium
Report
Levi & Korsinsky Reminds 23andMe Consumers of an Investigation into Recent Data Breach